1. Home
  2. Labeler Index
  3. Nucarepharmaceuticals, Inc.
  4. 68071-3301
  5. Product Images: Losartan Potassium

Product Images Losartan Potassium

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. pdp - 68071 3301 03 T47
  2. Figure 1 - 92296151 e507 41b4 a040 c01b87ecb982 01
  3. figure 2 - 92296151 e507 41b4 a040 c01b87ecb982 02
  4. figure 3 - 92296151 e507 41b4 a040 c01b87ecb982 03
  5. figure 4 - 92296151 e507 41b4 a040 c01b87ecb982 04
  6. figure 5 - 92296151 e507 41b4 a040 c01b87ecb982 05
  7. figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 06
  8. figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 07

Product Label Images

The following 8 images provide visual information about the product associated with Losartan Potassium NDC 68071-3301 by Nucarepharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 68071 3301 03 T47

pdp - 68071 3301 03 T47

This is a product description for Losartan Potassium 25mg tablets. It includes information such as the product number, expiration date, lot number, and the number of tablets in the package. It also provides a warning to keep the medication out of reach of children and store at a certain temperature.*

Figure 1 - 92296151 e507 41b4 a040 c01b87ecb982 01

Figure 1 - 92296151 e507 41b4 a040 c01b87ecb982 01

figure 2 - 92296151 e507 41b4 a040 c01b87ecb982 02

figure 2 - 92296151 e507 41b4 a040 c01b87ecb982 02

This text appears to be a statistical report on a study comparing the effects of Atenolol and Losartan Potassium Tablets on patients. It states that the adjusted risk reduction is 13%, with a p-value of 0.021. The study lasted for at least 65 months and may have been tracking the primary endpoint in patients. It is not clear what the primary endpoint is or what the study's results were.*

figure 3 - 92296151 e507 41b4 a040 c01b87ecb982 03

figure 3 - 92296151 e507 41b4 a040 c01b87ecb982 03

This appears to be a graph displaying patient data for a study comparing the effectiveness of Atenolol versus Losartan Potassium Tablets for preventing fatal and non-fatal stroke. The x-axis shows study months and the y-axis displays the percentage of patients affected. The graph shows a significant adjusted risk reduction of 25% for patients taking Losartan Potassium Tablets, with a p-value of 0.001.*

figure 4 - 92296151 e507 41b4 a040 c01b87ecb982 04

figure 4 - 92296151 e507 41b4 a040 c01b87ecb982 04

figure 5 - 92296151 e507 41b4 a040 c01b87ecb982 05

figure 5 - 92296151 e507 41b4 a040 c01b87ecb982 05

This is a table showing the percentage of patients with an event, with a risk reduction of 16.1%, and a value of 0.022. The table also mentions "Losartan Potassium Tablets" and "Placebo", suggesting that the data may be related to a clinical trial or study comparing the effectiveness of these medications.*

figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 06

figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 06

figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 07

figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 07

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.